TBol (Turinabol / Chlorodehydromethyltestosterone) 20mg is an oral anabolic steroid formulation supplied in a 50 tablet pack. Manufactured for consistent potency, stability, and research applications.
Format50 Tablets
Concentration20mg
Pay with Interac e-Transfer or Crypto
HPLC verified. COA on file for this batch
Ships from within Canada; No Customs
Discreet plain packaging; always
24h dispatch; Tracked Delivery
Turinabol, chemically known as Chlorodehydromethyltestosterone (4 Chlorodehydromethyltestosterone), is a unique oral anabolic compound structurally derived from Methandrostenolone (Dianabol) with a 4 chloro modification that fundamentally alters its hormonal activity profile, eliminating aromatization entirely and preventing the estrogenic conversion that characterises its parent compound. F40 Biotech’s formulation delivers 20mg per tablet in a 50 count format, sitting alongside CSD’s Axon Pharma Corp Turinabol 20mg 45 tablet listing with manufacturer and tablet count representing the primary differentiating variables between the two.
The 4 chloro structural modification that defines Turinabol’s research profile produces a non aromatizing oral anabolic compound with documented reduced SHBG binding compared to unmodified testosterone derivatives pharmacological characteristics that distinguish it clearly from Methandrostenolone despite their shared structural foundation. Turinabol’s historically significant background in East German state sponsored athletic research during the 1960s and 1970s generated an extensive longitudinal dataset on oral anabolic compound administration that continues to inform contemporary sports pharmacology research, making it one of the more historically documented oral anabolic compounds in the literature.
F40 Biotech formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COA documentation available on request. Researchers comparing options within CSD’s Turinabol range will find both the F40 Biotech 50 tablet and Axon Pharma Corp 45 tablet presentations at identical 20mg concentration. Manufacturer preference and tablet supply volume representing the sole differentiating variables. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.
Store in a cool, dry place away from direct light and heat. Intended for research purposes only.
Commonly researched alongside testosterone base compounds in comparative oral anabolic activity studies. Browse CSD’s full oral range and PCT compounds for complete protocol sourcing.
Turinabol (4-Chlorodehydromethyltestosterone) is a 17-alpha alkylated oral anabolic compound developed by East German pharmaceutical company Jenapharm in the 1960s; originally formulated as a modified combination of Dianabol and Clostebol. It demonstrates moderate anabolic activity with very low androgenic activity, does not aromatize to estrogen, and produces no water retention. Making it one of the most studied oral compounds for lean mass accretion, strength enhancement, and performance research without estrogen related side effects. Turinabol is particularly noted for significantly reducing SHBG increasing free testosterone ratio in concurrent compound protocols. Also known for its relatively mild hepatotoxicity compared to other 17-AA oral compounds at standard research doses.
Turinabol occupies a unique position between Dianabol and Anavar in the oral anabolic research catalogue. Compared to Dianabol, Turinabol produces slower, leaner gains without water retention or estrogen elevation, at the cost of reduced mass building potency. Compared to Anavar, Turinabol produces greater mass and strength gains with a slightly higher androgenic burden but at a lower cost per milligram. Turinabol is often described as producing Dianabol quality lean gains without the water retention and estrogen management requirements making it particularly studied for lean bulking and recomposition research protocols where quality tissue accretion without estrogen side effects is the objective.
Turinabol's 16 hour half-life is the longest of any commonly researched oral anabolic compound allowing once daily administration while maintaining stable plasma Turinabol levels throughout the day. This is a significant practical advantage over shorter half-life oral compounds such as Dianabol (3–5 hours) or Winstrol (8–9 hours) which require multiple daily doses for stable plasma levels. Once daily morning administration of the full research dose is the most common Turinabol research protocol; simple, convenient, and producing consistent plasma levels without split dosing complexity.
Due to its 16 hour half-life, Turinabol can be administered once daily, typically in the morning with or without food. Common male research doses range from 40–60mg daily (2–3 tablets at 20mg). Female research protocols use lower doses of 5–10mg daily where virilization risk minimization is the priority. The 50 tablet pack at 20mg provides 1000mg total; sufficient for 16–25 days of male research at 40–60mg daily, or up to 200 days of female research at 5mg daily. Research cycle duration typically ranges from 6–8 weeks for oral Turinabol protocols.
Yes! This batch has been independently HPLC tested by an accredited third party laboratory confirming concentration accuracy at 20mg per tablet and compound identity as 4-Chlorodehydromethyltestosterone. A certificate of analysis is available.
